Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The AAPS Journal|June 23, 2016
Improvement of Parameter Estimations in Tumor Growth Inhibition Models on Xenografted Animals: Handling Sacrifice Censoring and Error Caused by Experimental Measurement on Larger Tumor SizesPhilippe B Pierrillas, Michel Tod, Magali Amiel, et al.
The AAPS Journal|January 14, 2016
Improvement of Parameter Estimations in Tumor Growth Inhibition Models on Xenografted Animals: a Novel Method to Handle the Interval Censoring Caused by Measurement of Smaller TumorsPhilippe B Pierrillas, Michel Tod, Magali Amiel, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 22, 2022
Population pharmacokinetics of mobocertinib in healthy volunteers and patients with non-small cell lung cancerNeeraj Gupta, Philippe B Pierrillas, Michael J Hanley, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2025
Building Hybrid Pharmacometric-Machine Learning Models in Oncology Drug Development: Current State and RecommendationsAnna Fochesato, Logan Brooks, Omid Bazgir, et al.
The AAPS Journal|March 29, 2018
Correction to: Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2018
Tumor Growth Inhibition Modelling Based on Receptor Occupancy and Biomarker Activity of a New Bcl-2 Inhibitor in MicePhilippe B Pierrillas, Emilie Henin, Julien Ogier, et al.
The AAPS Journal|March 9, 2018
Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 20, 2025
A Model-Based Approach to Evaluate Anti-Drug Antibody Impact on Drug Exposure With Biologics: A Case Example With the CD3 T-Cell Bispecific CibisatamabJavier Sanchez, Philippe B Pierrillas, Nicolas Frey, et al.
Investigational New Drugs|May 27, 2020
Translational approach from preclinical to clinical: comparison of dose finding methods of a new Bcl2 inhibitor using PK-PD modeling and interspecies extrapolationPhilippe B Pierrillas, Emilie Henin, Julien Ogier, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2019
Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation StrategyPhilippe B Pierrillas, Emilie Henin, Kathryn Ball, et al.
Pageof 1